Previous 10 | Next 10 |
2023-08-21 18:12:53 ET More on Kenvue Kenvue rises on exchange offer oversubscription; JNJ falls Johnson & Johnson Vs. Kenvue: The Better Dividend Aristocrat Might Shock You Kenvue: A Buffett-Style Investment At A Reasonable Price Johnson & Jo...
Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600 Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600 PR Newswire NEW YORK , Aug. 21, 2023 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) will replace Advance ...
2023-08-14 01:23:21 ET Summary Emergent BioSolutions addresses public health threats; recent layoffs and operational cutbacks aim to save over $100 million annually. Despite Q2 2023 revenue increase, Emergent faces alarming cash burn, significant debt, and a predicted negative 3-y...
2023-08-09 00:30:51 ET Image source: The Motley Fool. Emergent BioSolutions (NYSE: EBS) Q2 2023 Earnings Call Aug 08, 2023 , 5:00 p.m. ET Operator Continue reading For further details see: Emergent BioSolutions (EBS) Q2 2023 Earnings Call...
2023-08-08 22:39:09 ET Emergent BioSolutions, Inc. (EBS) Q2 2023 Earnings Conference Call August 08, 2023, 17:00 ET Company Participants Matt Hartwig - IR Haywood Miller - Interim CEO Richard Lindahl - EVP, CFO & Treasurer Paul Williams - SVP, Products Bu...
2023-08-08 16:37:49 ET Emergent Biosolutions press release ( NYSE: EBS ): Q2 Non-GAAP EPS of -$1.06 misses by $0.43 . Revenue of $337.9M (+39.2% Y/Y) beats by $121.15M . Guidance FY: Total Revenues $1,000M - $1,100M vs $1.16B consensus; Adj. net loss $(195M) - ...
Reports Q2 2023 total revenues of $338M, above the prior guidance range, net loss of $261M and adjusted EBITDA of $56M Updates FY 2023 guidance and provides initial Q3 2023 forecast for total revenues GAITHERSBURG, Md., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:...
2023-08-08 08:05:12 ET Emergent BioSolutions ( NYSE: EBS ) Tuesday said it was reducing investment in its CDMO services business, and would lay off of about 400 employees across all areas of the company. As a result, Emergent would also cut operations at its Bayview facility i...
Actions bring sharpened focus on MCM and NARCAN ® Nasal Spray products Expected to improve operational efficiencies and deliver annual cost savings over $100 million annually GAITHERSBURG, Md., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced ...
2023-08-01 08:26:13 ET Stock futures dipped early Tuesday as the corporate earnings season kicks into high gear. Here are some of Tuesday's biggest stock movers in premarket trading: Biggest stock gainers For further details see: Biggest stock movers today: Arista Netwo...
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of a new opio...
GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second quarter 2024, key business updates, revenue guidance for the third quarter of...
The extension to a four-year shelf-life helps improve naloxone access as communities continue to grapple with the growing opioid epidemic; product with the extended shelf life has officially begun shipping WINNIPEG, Manitoba, July 22, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolution...